Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation

计划入组 55 人 · 首次发布于 2015 年 4 月 17 日

Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation

计划入组 55 人 · 首次发布于 2017 年 1 月 2 日

RESist Against Irritability Superiority Trial

计划入组 270 人 · 首次发布于 2022 年 9 月 6 日

Passiflora incarnata flower

Haloperidol(Haldol)

C₂₁H₂₃ClFNO₂ · Rx

Aripiprazole(Abilify, Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), Abilify Maintena, Aripiprazole Accord, Aripiprazole Sandoz, Aripiprazole Zentiva)

C₂₃H₂₇Cl₂N₃O₂ · Rx

PleoPharma Doses First Patient in Pivotal Phase 3 Trial of PP-01 for Cannabis Withdrawal, Presents Phase 2 Data Showing 43% Reduction in Irritability

ART-501 Shows Promise in Phase 2a Trial for Autism Spectrum Disorder Treatment

Presidential Executive Order Reclassifies Cannabis, Accelerating DeFloria's Phase 2 Autism Drug Development